Silver Book Fact

Early Gene Therapy Studies Show Promise for Parkinson’s Disease

Fact image

Lopes J. AXO-Lenti-PD Gene Therapy Shows Benefits in 2 Advanced Parkinson’s Patients in Phase 1/2 Trial. Parkinson's News Today. March 14 2019. https://parkinsonsnewstoday.com/2019/03/14/axo-lenti-pd-gene-therapy-shows-benefits-2-patients-phase-1-2-trial/. Accessed June 11, 2019

Christine C, Bankiewicz K, Van Laar A, Richardson R, et al. Magnetic Resonance Imaging-Guided Phase 1 Trial of Putanimal AADC Gene Therapy for Parkinson’s Disease. Ann Neurol. 2019; 85(5). https://www.onlinelibrary.wiley.com/doi/10.1002/ana.25450

Reference

Title
AXO-Lenti-PD Gene Therapy Shows Benefits in 2 Advanced Parkinson’s Patients in Phase 1/2 Trial
Publication
Parkinson's News Today
Publication Date
March 14 2019
Authors
Lopes J
URL
Read Full Resource
Title
Magnetic Resonance Imaging-Guided Phase 1 Trial of Putanimal AADC Gene Therapy for Parkinson’s Disease
Publication
Ann Neurol
Publication Date
2019
Authors
Christine C, Bankiewicz K, Van Laar A, Richardson R, et al.
Volume & Issue
Volume 85, Issue 5
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • Medicines Allow Patients to Remain Independent Longer: New Alzheimer’s medicine delays need for costly home care  
  • More Effective Treatment of Alzheimer’s Disease Could Save Billions: Combined Medicare and Medicaid savings from effective treatment of Alzheimer’s diease  
  • Medicaid Costs, 5-Year Delayed Onset  
  • An Alzheimer’s disease treatment breakthrough that slowed its progression and began to show its effects in 2015, would reduce the Medicare costs for people with the disease in 2050 by…  
  • If an Alzheimer’s disease treatment breakthrough that delayed the age of onset by 5 years was introduced in 2015, by 2020 total cost of care (for all payers) for all people…